Anna L. Gray

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1^G93A mouse model of ALS

Bernadett Kalmár, Sergey S. Novoselov, Anna L. Gray et al. · Journal of Neurochemistry · 2008 · 163 citations

Life Sciences, Neurology, Neuroscience +17

A comprehensive assessment of the <i>SOD1G93A</i> low-copy transgenic mouse, which models human amyotrophic lateral sclerosis

Abraham Acevedo‐Arozena, Bernadett Kalmár, Shafa Essa et al. · Disease Models & Mechanisms · 2011 · 108 citations · Full text

Life Sciences, Genetics, Neurology +17

Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity

Ramon Garcia‐Cortadella, Gerrit Schwesig, Christoph Jeschke et al. · Nature Communications · 2021 · 92 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors

Anna L. Gray, Richard Karlsson, Abigail R. E. Roberts et al. · Cell Reports · 2023 · 73 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy

Bilal Malik, Niranjanan Nirmalananthan, Anna L. Gray et al. · Brain · 2013 · 64 citations · Full text

Medicine, Neurology, Neuroscience +17